Published: Thu, February 15, 2018
Business | By Tara Barton

Evercore Wealth Management LLC Boosted Idexx Labs INC (IDXX) Holding


The institutional investor held 7,449 shares of the computer manufacturing company at the end of 2017Q3, valued at $1.15M, down from 9,468 at the end of the previous reported quarter. The stock decreased 0.76% or $1.401 during the last trading session, reaching $182.319. The shares were sold at an average price of $177.52, for a total value of $3,905,440.00. (NYSE:HD) has risen 18.65% since February 14, 2017 and is uptrending. It has outperformed by 35.65% the S&P500.

Evercore Wealth Management Llc increased its stake in Idexx Labs Inc (IDXX) by 693.28% based on its latest 2017Q3 regulatory filing with the SEC. Evercore Wealth Management Llc bought 55,462 shares as the company's stock rose 13.64% with the market. The institutional investor held 34,281 shares of the health care company at the end of 2017Q3, valued at $5.33M, down from 39,429 at the end of the previous reported quarter. Evercore Wealth Management Llc who had been investing in Idexx Labs Inc for a number of months, seems to be bullish on the $15.30B market cap company. The stock increased 0.23% or $0.4 during the last trading session, reaching $175.46. About 429,796 shares traded. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 83.30% since February 15, 2017 and is uptrending. It has outperformed by 66.60% the S&P500.

Analysts await The Williams Companies, Inc. (NASDAQ:IDXX) on Friday, July 24 to "Hold" rating. Therefore 73% are positive. (NASDAQ:IDXX). Ruane Cunniff Goldfarb Inc reported 2,919 shares stake. The rating was maintained by Jefferies on Wednesday, September 13 with "Buy". The stock of Apple Inc. Topeka Capital Markets maintained Qualys, Inc. Argus Research has "Buy" rating and $135 target. The company was upgraded on Friday, July 24 by Feltl & Co. Cambridge Research Advsrs Incorporated reported 17,374 shares. The rating was maintained by BMO Capital Markets with "Buy" on Monday, December 18. J.P. Morgan has "Buy" rating and $17600 target. On Friday, November 3 the stock rating was maintained by FBN Securities with "Buy". Profund Advisors Limited Liability Co owns 8,747 shares for 0.06% of their portfolio.

Since August 14, 2017, it had 0 insider purchases, and 10 insider sales for $2.48 million activity. Also, VP Brian P. Mckeon sold 6,602 shares of the firm's stock in a transaction dated Monday, February 5th. AHRENDTS ANGELA J sold $9.78M worth of stock. AYERS JONATHAN W also sold $3.91M worth of IDEXX Laboratories, Inc. $213,309 worth of Qualys, Inc. (NASDAQ IDXX) traded up $2.87 on Thursday, hitting $178.26.

Investors sentiment increased to 1.63 in Q3 2017. Its up 0.13, from 1.06 in 2017Q2. 66 funds opened positions while 223 raised stakes. Colony Group Limited Liability owns 1,772 shares. Wexford Cap Ltd Partnership stated it has 0.03% in Qualys, Inc. The MA Aureus Asset Management Llc owns 7548 shares. Winslow Evans And Crocker accumulated 0.09% or 1,800 shares. (NASDAQ:QLYS) for 61,667 shares. (NASDAQ:QLYS). Rhumbline Advisers owns 0.01% invested in Qualys, Inc. Td Asset Mngmt reported 44,095 shares stake. (NASDAQ:QLYS) for 22,697 shares. Somerville Kurt F, Massachusetts-based fund reported 2,500 shares. (NASDAQ:AAPL) for 1.13 million shares.

Investors sentiment decreased to 0.86 in Q3 2017. Its up 0.19, from 1.44 in 2017Q2. 121 funds opened positions while 587 raised stakes.

Feds fine US Bancorp $613 million for money-laundering violations
The government will dismiss the charges if the bank abides by its promises, including reforming its anti-money-laundering program. Bancorp, a longtime holding of Warren Buffett 's Berkshire Hathaway , were unchanged in morning trading Thursday.

IDEXX Laboratories, Inc. has a fifty-two week low of $140.99 and a fifty-two week high of $198.73. (NASDAQ:IDXX) for 352,885 shares. IDEXX Laboratories's quarterly revenue was up 14.2% compared to the same quarter last year. equities research analysts forecast that IDEXX Laboratories, Inc. will post 4.09 EPS for the current fiscal year. IDEXX Laboratories, Inc.'s RSI is presently sitting at 53.26. (NASDAQ:IDXX) for 621,160 shares. Virginia Retirement System Et Al invested in 15,100 shares.

Tocqueville Asset Mngmt Limited Partnership accumulated 8,022 shares. (NASDAQ:IDXX). Bridgewater Assocs Ltd Partnership has invested 0% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares. AYERS JONATHAN W had sold 36,000 shares worth $6.45M on Monday, February 5. Advisors Capital Management LLC bought a new stake in IDEXX Laboratories in the 3rd quarter valued at $262,000. Goldman Sachs Group Inc Inc reported 0.02% in IDEXX Laboratories, Inc. Mogy Joel R Counsel has invested 1.3% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 85 shares. Bank & Trust Of Mellon has 955,225 shares for 0.04% of their portfolio. Lord Abbett Ltd Liability Corporation accumulated 113,735 shares. Omers Administration has 0.04% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Fifth Third Bancorp invested 0% in IDEXX Laboratories, Inc. Claflin Bruce L. bought 1,000 shares worth $179,580.

Canaccord Genuity restated their buy rating on shares of IDEXX Laboratories (NASDAQ:IDXX) in a report released on Monday, January 29th. Looking back further, IDEXX Laboratories, Inc. stock has been 12.92% over the last six months, and 12.16% since the start of the calendar year. (NASDAQ:IDXX) was sold by HENDERSON REBECCA M on Tuesday, August 22. Therefore 64% are positive. Four analysts have made estimates for IDEXX Laboratories' earnings, with the lowest sales estimate coming in at $522.70 million and the highest estimate coming in at $527.53 million. The firm earned "Outperform" rating on Wednesday, April 13 by Credit Suisse. The firm has "Buy" rating by Canaccord Genuity given on Wednesday, July 20. The rating was maintained by Bank of America with "Buy" on Wednesday, August 16. Canaccord Genuity maintained the stock with "Buy" rating in Thursday, October 5 report. IDEXX Laboratories had a negative return on equity of 432.19% and a net margin of 13.36%. The company was downgraded on Friday, August 28 by Raymond James. Finally, Piper Jaffray Companies increased their price objective on IDEXX Laboratories to $211.00 and gave the company an "overweight" rating in a report on Thursday, February 1st. Stifel Nicolaus has "Buy" rating and $185.0 target.

Hwg Holdings Lp, which manages about $127.19M US Long portfolio, upped its stake in Applied Optoelectronicsinc Com (Call) (NASDAQ:AAOI) by 5,600 shares to 116,500 shares, valued at $7.53 million in 2017Q3, according to the filing.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Like this: